SCHEMBL4543302

SCHEMBL4543302

O=COCC(Br)(Br)[N+](=O)[O-]

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.34
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8856153 0.82 LMNA (0.44) LMNAALDH1A1
SCHEMBL27584288 0.76 ALDH1A1 (0.33) ALDH1A1
SCHEMBL7454501 0.76 ALDH1A1 (0.33) ALDH1A1
SCHEMBL10823178 0.73 ALDH1A1 (0.31) ALDH1A1
SCHEMBL28442 0.69
SCHEMBL3293711 0.66 LMNA (0.46) LMNAALDH1A1
SCHEMBL11700851 0.65
SCHEMBL543992 0.65
SCHEMBL7781961 0.64
SCHEMBL21431010 0.63 ALDH1A1 (0.30) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10983615-B2 Patterning of a composition comprising silver nanowires Heraeus Deutschland GmbH & Co. KG (DE) 2021-04-20 US disclosed
US-10671192-B2 Process for the production of a layered body and layered bodies obtainable therefrom Heraeus Deutschland GmbH & Co. KG (DE) 2020-06-02 US disclosed
EP-2729845-B1 PROCESS FOR THE PRODUCTION OF A LAYERED BODY HERAEUS DEUTSCHLAND GMBH & CO KG (DE) 2019-09-04 EP disclosed
US-20180341346-A1 PATTERNING OF A COMPOSITION COMPRISING SILVER NANOWIRES HERAEUS DEUTSCHLAND GMBH & CO KG (DE) 2018-11-29 US disclosed
US-10073549-B2 Patterning of a composition comprising silver nanowires Heraeus Deutschland GmbH & Co. KG (DE) 2018-09-11 US disclosed
US-20160162063-A1 PATTERNING OF A COMPOSITION COMPRISING SILVER NANOWIRES Heraeus Deutschland GmbH & Co. KG (DE) 2016-06-09 US disclosed
EP-2638547-B1 METHOD FOR PRODUCING LAYER STRUCTURES BY TREATMENT WITH ORGANIC ETCHANTS AND LAYER STRUCTURES OBTAINABLE THEREFROM HERAEUS DEUTSCHLAND GMBH & CO KG (DE) 2015-07-08 EP disclosed
WO-2015010778-A1 PATTERNING OF A COMPOSITION COMPRISING SILVER NANOWIRES HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) 2015-01-29 WO disclosed
EP-2830110-A1 Patterning of a composition comprising silver nanowires Heraeus Precious Metals GmbH & Co. KG (DE) 2015-01-28 EP disclosed
US-20140313433-A1 Process for the Production of a Layered Body and Layered Bodies Obtainable Therefrom HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) 2014-10-23 US disclosed
EP-2729846-A1 PROCESS FOR THE PRODUCTION OF A LAYERED BODY AND LAYERED BODIES WITHOUT MASKING OBTAINABLE THEREFROM Heraeus Precious Metals GmbH & Co. KG (DE) 2014-05-14 EP disclosed
US-20130295354-A1 METHOD FOR PRODUCING LAMINATED ARTICLES BY TREATMENT WITH ORGANIC ETCHANTS AND LAMINATED ARTICLES OBTAINABLE THEREFROM HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) 2013-11-07 US disclosed
EP-2638547-A1 METHOD FOR PRODUCING LAYER STRUCTURES BY TREATMENT WITH ORGANIC ETCHANTS AND LAYER STRUCTURES OBTAINABLE THEREFROM Heraeus Precious Metals GmbH & Co. KG (DE) 2013-09-18 EP disclosed
WO-2013007362-A1 PROCESS FOR THE PRODUCTION OF A LAYERED BODY AND LAYERED BODIES OBTAINABLE THEREFROM HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) 2013-01-17 WO disclosed
WO-2013007363-A1 PROCESS FOR THE PRODUCTION OF A LAYERED BODY AND LAYERED BODIES WITHOUT MASKING OBTAINABLE THEREFROM HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) 2013-01-17 WO disclosed
WO-2012062446-A1 METHOD FOR PRODUCING LAYER STRUCTURES BY TREATMENT WITH ORGANIC ETCHANTS AND LAYER STRUCTURES OBTAINABLE THEREFROM HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) 2012-05-18 WO disclosed
US-6881418-B2 Microbicidal deodorant in a tractable liquid form that has excellent longterm storage stability. The microbicidal deodorant of the present invention comprises: at least one substance selected from the group consisting of halogenated K.I CHEMICAL INDUSTRY CO., LTD. (JP) 2005-04-19 US disclosed
EP-1393628-A1 LIQUID DEODORANT KILLING MICROORGANISM AND METHOD OF MICROORGANISM-KILLING DEODORIZATION K I CHEMICAL INDUSTRY CO., LTD. (JP) 2004-03-03 EP disclosed
JP-2003261517-A NEW DIBROMONITRO COMPOUND AND APPLICATION THEREOF K I CHEMICAL INDUSTRY CO LTD 2003-09-19 JP disclosed
US-20030157051-A1 Liquid deodorant killing microorganism and method of microorganism-killing deodorization K.I. CHEMICAL INDUSTRY CO., LTD. (JP) 2003-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030157051-A1 Liquid deodorant killing microorganism and method of microorganism-killing deodorization DAO, DDT, DIMT1 LMNA 4245/4885ALDH1A1 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.